Literature DB >> 17922802

Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae.

M Elia1, M B Engfer, C J Green, D B A Silk.   

Abstract

BACKGROUND: Enteral nutrition can be associated with gastrointestinal side effects and fibre supplementation has been proposed as a means to normalize bowel function. AIM: To evaluate systematically the effects of fibre supplementation of enteral feeds in healthy volunteers and patients both in the hospital and community settings.
METHODS: Electronic and manual bibliographic searches were conducted. Controlled studies in adults or children, comparing fibre-supplemented vs. fibre-free formulae given as the sole source of nutrition for at least 3 days, were included.
RESULTS: Fifty-one studies (including 43 randomized-controlled trials), enrolling 1762 subjects (1591 patients and 171 healthy volunteers) met the inclusion criteria. Fibre supplementation was generally well tolerated. In the hospital setting, the incidence of diarrhoea was reduced as a result of fibre administration (OR 0.68, 95% CI: 0.48-0.96; 13 randomized-controlled trials). Meta-regression showed a more pronounced effect when the baseline incidence of diarrhoea was high. In both patients and healthy subjects, fibre significantly reduced bowel frequency when baseline frequency was high and increased it when it was low, revealing a significant moderating effect of fibre.
CONCLUSIONS: The review indicates that the fibre-supplemented enteral formulae have important physiological effects and clinical benefits. There is a need to use a consistent approach to undertake more studies on this issue in the community setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922802     DOI: 10.1111/j.1365-2036.2007.03544.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  21 in total

Review 1.  Gastroenteric tube feeding: techniques, problems and solutions.

Authors:  Irina Blumenstein; Yogesh M Shastri; Jürgen Stein
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Impact of Soluble Fiber in the Microbiome and Outcomes in Critically Ill Patients.

Authors:  Carla Venegas-Borsellino; Minkyung Kwon
Journal:  Curr Nutr Rep       Date:  2019-12

Review 3.  Diarrhoea in the enterally fed patient.

Authors:  T E Bowling
Journal:  Frontline Gastroenterol       Date:  2010-07-28

Review 4.  Evidence-based use of enteral nutrition in acute pancreatitis.

Authors:  Attila Oláh; László Romics
Journal:  Langenbecks Arch Surg       Date:  2010-03-23       Impact factor: 3.445

Review 5.  Fiber and prebiotic supplementation in enteral nutrition: A systematic review and meta-analysis.

Authors:  Mazuin Kamarul Zaman; Kin-Fah Chin; Vineya Rai; Hazreen Abdul Majid
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

6.  Relationship Between Dietary Fiber Intake and Short-Chain Fatty Acid-Producing Bacteria During Critical Illness: A Prospective Cohort Study.

Authors:  Yichun Fu; Dagmara I Moscoso; Joyce Porter; Suneeta Krishnareddy; Julian A Abrams; David Seres; David H Chong; Daniel E Freedberg
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-08-06       Impact factor: 4.016

Review 7.  Fiber in the ICU: Should it Be a Regular Part of Feeding?

Authors:  Caitlin H Green; Rebecca A Busch; Jayshil J Patel
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02

8.  Digestion-resistant maltodextrin effects on colonic transit time and stool weight: a randomized controlled clinical study.

Authors:  María Salud Abellán Ruiz; María Dolores Barnuevo Espinosa; Carlos J Contreras Fernández; Antonio J Luque Rubia; Francisca Sánchez Ayllón; Miriam Aldeguer García; Carlos García Santamaría; Francisco Javier López Román
Journal:  Eur J Nutr       Date:  2015-10-06       Impact factor: 5.614

9.  An investigation of fecal volatile organic metabolites in irritable bowel syndrome.

Authors:  Iftikhar Ahmed; Rosemary Greenwood; Ben de Lacy Costello; Norman M Ratcliffe; Chris S Probert
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

10.  Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.

Authors:  Natalia Zeber-Lubecka; Maria Kulecka; Filip Ambrozkiewicz; Agnieszka Paziewska; Krzysztof Goryca; Jakub Karczmarski; Tymon Rubel; Wojciech Wojtowicz; Piotr Mlynarz; Lukasz Marczak; Roman Tomecki; Michal Mikula; Jerzy Ostrowski
Journal:  Gut Microbes       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.